DXE3/Ztm |
post-insult time to onset of experimental arthritis |
pristane (150 ul) (for 110 days) |
Nordquist N, et al., J Autoimmun 2000 Dec;15(4):425-32. |
joint integrity trait |
both |
0 days
| 1 |
|
43.0 |
d |
|
|
in vivo visual assessment |
9504000.0 |
|
0 |
|
|
70145 |
1298 |
LEW.1AV1 |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
male |
0 days
| 1 |
median |
22.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69641 |
1161 |
LEW.1F |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56 days-98 days |
10 |
|
17.0 |
d |
1.26 |
4.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69669 |
1159 |
PVG.1AV1 |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
15 |
|
14.6 |
d |
0.4 |
1.55 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69778 |
1162 |
DA.PVG.1AV1-(D4Rat155-Spr) |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
14 |
|
14.3 |
d |
0.3 |
1.12 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69780 |
1162 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
17 |
|
12.1 |
d |
0.3 |
1.24 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69784 |
1162 |
DA.PVG.1AV1-(D4Rat155-Spr) |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
24 |
|
12.5 |
d |
0.5 |
2.45 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69787 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
post-insult time to onset of experimental arthritis |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
|
16.9 |
d |
0.6 |
1.9 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69789 |
1162 |
DA.PVG.1AV1-(D4Rat113-D4Rat62)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 18 |
|
14.8 |
d |
0.75 |
3.2 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84926 |
1301 |
DA/ZtmKini |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
male |
0 days
| 24 |
|
14.6 |
d |
1.39 |
6.8 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84467 |
1301 |
LEW.1AV1.DA-(D10Wox17-D10Rat135)/Ubc |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
female |
0 days
| 13 |
median |
22.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69650 |
1161 |
DXE1/Ztm |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56 days-98 days |
20 |
|
31.0 |
d |
4.7 |
21.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69673 |
1159 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
male |
120 days-200 days |
9 |
|
15.2 |
d |
0.2 |
0.6 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69782 |
1162 |
PVG.1AV1.DA-(D4Mgh17-D4Rat84)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 16 |
|
20.2 |
d |
2.98 |
11.9 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84910 |
1301 |
DA.PVG.1AV1-(D4Rat203-D4Mit22)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 10 |
|
12.6 |
d |
0.32 |
1.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84918 |
1301 |
LEW.1AV1 |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
female |
0 days
| 2 |
median |
18.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69640 |
1161 |
LEW.1AV1.DA-(D10Wox17-D10Rat135)/Ubc |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
male |
0 days
| 17 |
median |
24.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69651 |
1161 |
DA.PVG.1AV1-(D4Mgh17-D4Rat56) |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
11 |
|
15.4 |
d |
0.5 |
1.66 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69781 |
1162 |
LEW.1F |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Lu S, et al., Eur J Hum Genet 2002 Aug;10(8):475-83. |
joint integrity trait |
male |
56 days-84 days |
14 |
|
31.0 |
d |
7.0 |
26.19 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69817 |
1163 |
DA.PVG.1AV1-(D4Rat113-D4Kiru96)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 8 |
|
14.4 |
d |
1.73 |
4.9 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84923 |
1301 |
DA/ZtmKini |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
female |
0 days
| 24 |
|
14.6 |
d |
0.63 |
3.1 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84468 |
1301 |
DA/ZtmKini |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 6 |
|
16.3 |
d |
0.94 |
2.3 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84472 |
1301 |
DA/ZtmRhd |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
|
14.0 |
d |
0.32 |
1.0 |
in vivo visual assessment |
1.296E7 |
|
0 |
|
|
70131 |
1282 |
DA.PVG.1AV1-(D4Rat231-D4Mit12)/Kini |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 11 |
|
13.3 |
d |
0.54 |
1.8 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84922 |
1301 |
DA.PVG.1AV1-(D4Rat113-D4Kiru80)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 11 |
|
17.2 |
d |
1.63 |
5.4 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84925 |
1301 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
15 |
|
13.0 |
d |
0.4 |
1.55 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69773 |
1162 |
DA.PVG.1AV1-(D4Mgh17-D4Rat56) |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
male |
120 days-200 days |
13 |
|
15.5 |
d |
0.2 |
0.72 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69783 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
|
16.4 |
d |
0.8 |
2.53 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69791 |
1162 |
LEW.1F |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Lu S, et al., Eur J Hum Genet 2002 Aug;10(8):475-83. |
joint integrity trait |
female |
56 days-84 days |
8 |
|
18.0 |
d |
1.0 |
2.83 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69818 |
1163 |
LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
female |
0 days
| 17 |
median |
24.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69648 |
1161 |
LEW.1AV1.DA-(D10Got154-D10Rat135)/Ubc |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
female |
0 days
| 26 |
median |
22.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69652 |
1161 |
DA.PVG.1AV1-(D4Mgh17-D4Rat56) |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 7 |
|
12.4 |
d |
0.49 |
1.3 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
70200 |
1301 |
DA/Bkl |
post-insult time to onset of experimental arthritis |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
joint integrity trait |
both |
66 days-126 days |
105 |
|
15.0 |
d |
0.2 |
2.0 |
in vivo visual assessment |
0.0 |
immunized |
10 |
days |
variable |
68143 |
850 |
DA/ZtmKini |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 27 |
|
14.0 |
d |
1.06 |
5.5 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
70194 |
1301 |
DA/ZtmKini |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 5 |
|
12.2 |
d |
0.18 |
0.4 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
70196 |
1301 |
DA.PVG.1AV1-(D4Rat155-Spr) |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 12 |
|
13.7 |
d |
0.43 |
1.5 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
70198 |
1301 |
LEW.1AV1.DA-(D10Rat92-D10Rat135)/Ubc |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
female |
0 days
| 11 |
median |
18.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69638 |
1161 |
LEW.1AV1.DA-(D10Got154-D10Rat135)/Ubc |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
male |
0 days
| 28 |
median |
24.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69653 |
1161 |
LEW.1N |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56 days-98 days |
11 |
|
21.0 |
d |
2.11 |
7.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69670 |
1159 |
DA.PVG.1AV1-(D4Rat155-D4Rat84) |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
16 |
|
13.1 |
d |
1.1 |
4.4 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69786 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 11 |
|
14.0 |
d |
0.42 |
1.4 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84917 |
1301 |
DA.PVG.1AV1-(D4Mit22-D4Rat84)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 12 |
|
13.0 |
d |
0.38 |
1.3 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84919 |
1301 |
DA.PVG.1AV1-(D4Rat155-D4Rat84) |
post-insult time to onset of experimental arthritis |
Freund's complete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
14 |
|
13.6 |
d |
0.4 |
1.5 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69776 |
1162 |
DA/ZtmRhd |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Olofsson P, et al., J Immunol 2003 Jul 1;171(1):407-16. |
joint integrity trait |
both |
56 days-84 days |
104 |
|
12.0 |
d |
0.2 |
2.04 |
in vivo visual assessment |
2419200.0 |
|
0 |
|
|
69842 |
1164 |
DA.PVG-(D4Rat141-D4Mgh11) |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 30 |
|
31.7 |
d |
1.86 |
10.2 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
70195 |
1301 |
DA.PVG.1AV1-(D4Rat63-D4Rat84)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 9 |
|
17.0 |
d |
0.93 |
2.8 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84900 |
1301 |
LEW.1AV1.DA-(D4Mgh17-D4Rat203)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 13 |
|
16.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84903 |
1301 |
DA.PVG.1AV1-(D4Got126-D4Rat203)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 7 |
|
12.7 |
d |
0.45 |
1.2 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84920 |
1301 |
DA/Bkl |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (0.1 ml) |
Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 |
joint integrity trait |
male |
70 days-105 days |
10 |
|
14.4 |
d |
1.3 |
4.11 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69554 |
1158 |
E3 |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
|
0.0 |
d |
|
|
in vivo visual assessment |
1.296E7 |
|
0 |
|
|
70132 |
1282 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
female |
0 days
| 8 |
median |
14.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69636 |
1161 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
male |
0 days
| 6 |
median |
14.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69637 |
1161 |
LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
male |
0 days
| 6 |
median |
22.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69649 |
1161 |
DA.PVG.1AV1-(D4Rat155-D4Rat84) |
post-insult time to onset of experimental arthritis |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
11 |
|
16.0 |
d |
0.4 |
1.33 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69774 |
1162 |
DA.PVG.1AV1-(D4Rat155-D4Rat113)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 9 |
|
14.4 |
d |
0.73 |
2.2 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84915 |
1301 |
DA.PVG.1AV1-(D4Rat62-D4Got136)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 12 |
|
15.4 |
d |
0.66 |
2.3 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84921 |
1301 |
DA.PVG.1AV1-(D4Rat155-D4Rat84) |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
14 |
|
17.6 |
d |
0.8 |
2.99 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69779 |
1162 |
PVG.1AV1 |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
18 |
|
38.0 |
d |
1.2 |
5.09 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69785 |
1162 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
9 |
|
14.0 |
d |
0.7 |
2.1 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69788 |
1162 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
|
15.5 |
d |
0.8 |
2.53 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69793 |
1162 |
LEW/Han |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56 days-98 days |
11 |
|
23.0 |
d |
3.02 |
10.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69668 |
1159 |
DA/ZtmRhd |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56 days-98 days |
17 |
|
14.0 |
d |
0.49 |
2.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69671 |
1159 |
DA/ZtmRhd |
post-insult time to onset of experimental arthritis |
pristane (150 ul) (for 56 days) |
Vingsbo-Lundberg C, et al., Nat Genet 1998 Dec;20(4):401-4 |
joint integrity trait |
both |
0 days
| 30 |
|
14.0 |
d |
0.37 |
2.0 |
in vivo visual assessment |
4838400.0 |
|
0 |
|
|
69593 |
1160 |
DA.PVG.1AV1-(D4Rat63-D4Rat203) |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 37 |
|
14.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
70202 |
1301 |
DA/Bkl |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (0.1 ml) |
Cannon GW, et al., J Rheumatol 1993 Jan;20(1):7-11 |
joint integrity trait |
male |
70 days-105 days |
12 |
|
15.8 |
d |
3.3 |
11.43 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69553 |
1158 |
LEW.1AV1.DA-(D10Rat92-D10Rat135)/Ubc |
post-insult time to onset of experimental arthritis |
squalene (860 mg/ml) |
Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. |
joint integrity trait |
male |
0 days
| 11 |
median |
18.0 |
d |
|
|
in vivo visual assessment |
0.0 |
|
0 |
|
|
69639 |
1161 |
E3/ZtmRhd |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56 days-98 days |
23 |
|
38.0 |
d |
1.25 |
6.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69672 |
1159 |
DXE2/Ztm |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56 days-98 days |
24 |
|
72.0 |
d |
6.94 |
34.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69674 |
1159 |
DXE3/Ztm |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56 days-98 days |
20 |
|
32.0 |
d |
3.35 |
15.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69675 |
1159 |
LEW.1F |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
11 |
|
17.0 |
d |
0.9 |
3.0 |
in vivo visual assessment |
1.296E7 |
|
0 |
|
|
70133 |
1282 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
Freund's complete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
16 |
|
14.9 |
d |
0.5 |
2.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69775 |
1162 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
12 |
|
14.5 |
d |
0.5 |
1.73 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69777 |
1162 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
|
14.2 |
d |
0.4 |
1.26 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69790 |
1162 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
|
14.2 |
d |
1.1 |
3.48 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
69792 |
1162 |
DA.PVG.1AV1-(D4Got126-D4Got136) |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 14 |
|
19.0 |
d |
1.18 |
4.4 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84924 |
1301 |
DA/ZtmKini |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 15 |
|
14.9 |
d |
1.52 |
5.9 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84471 |
1301 |
DA.PVG.1AV1-(D4Rat203-D4Got130)/Kiru |
post-insult time to onset of experimental arthritis |
Freund's incomplete adjuvant (200 ul) |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
joint integrity trait |
both |
0 days
| 11 |
|
14.9 |
d |
1.03 |
3.4 |
in vivo visual assessment |
0.0 |
|
0 |
|
|
84916 |
1301 |